Retatrutide 10MG (GLP-3 "RET")
Novel retatrutide-class tri-agonist peptide studied in research for GIP, GLP-1, and glucagon receptor activity.
These products are sold strictly for in-vitro laboratory research and are not intended for human consumption, diagnosis, treatment, or any therapeutic use. Purchaser must be 18 years of age or older and confirms they are a qualified researcher.
Compound identity
Listed on the storefront as GLP-3 "RET". The verified compound identity for this research vial is below.
- Compound name
- Retatrutide
- Also known as
- Retatrutide, LY3437943, GLP-3 RET, Triple agonist peptide
- Molecular formula
- C221H342N46O68
- Molecular weight
- Approximately 4,731 Da
- CAS number
- 2381089-83-2
- Vial size
- 10MG
Product Information
Research DatasheetProduct Overview
Retatrutide is a synthetic investigational peptide designed as a triple receptor agonist targeting the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors. It is widely studied in laboratory settings to investigate metabolic signaling, energy homeostasis, glucose regulation, lipid metabolism, and receptor pharmacology. This lyophilized research peptide is manufactured under sterile conditions and undergoes third-party analytical testing for identity and purity. For laboratory research use only. Not for human or veterinary use.
Molecular Profile
Research Applications
- ◆Triple incretin receptor pharmacology
- ◆Metabolic signaling pathway research
- ◆Glucose homeostasis investigations
- ◆Energy expenditure studies
- ◆Lipid metabolism research
- ◆Endocrine signaling investigations
- ◆Receptor binding and activation studies
- ◆Obesity and metabolic disease laboratory models
- ◆Peptide pharmacokinetics and stability research
- ◆Drug discovery and translational peptide research
Quality Standards
For in-vitro research use only. Not for human consumption, diagnosis, or treatment.
Novel retatrutide-class tri-agonist peptide studied in research for GIP, GLP-1, and glucagon receptor activity. All ENOS research vials are lyophilized, sealed under sterile conditions, and shipped with cold-chain packaging where appropriate. A downloadable Certificate of Analysis is available on request for every batch.
You may also like
GLP-3 "RET"
GLP-3 "RET" · 20MG
Higher-yield retatrutide research vial.
GLP-3 "RET"
GLP-3 "RET" · 60MG
Highest-yield retatrutide research vial.
GLP-2 "TIRZ"
GLP-2 "TIRZ" · 10MG
Dual GIP/GLP-1 agonist research peptide.